The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon
Work +91 11 46667000

The firm: Singh & Associates is an ISO 9001:2008 certified full-service law firm, headquartered in New Delhi. It has a pan-India presence, with offices strategically situated at Mumbai, Bangalore and Gurugram. The firm has four major practice groups which are, litigation and ADR, contracts and transactions, corporate and tax, and intellectual property. The firm has created its own niche by providing quality legal services accompanied with excellent turnaround time and competitive fees. The firm has a strong team of professionals including experienced lawyers (with in-house advocacy expertise), chartered accountants, company secretaries, trade mark attorneys, patent agents, engineers and specialised paralegal staff. Singh & Associates was presented with the Excellence in Professional Services Award 2017 by Indo-American Chamber Of Commerce (IACC). The firm has also been awarded the Law Firm of Year Award at India Legal Awards 2016 and a 'Notable Firm' by Asia Legal Business M&A Rankings 2016, and 2016 also saw the founding partner, Manoj K Singh, featuring as One of the 100 Legal Luminaries of India for the year 2016, described as 'excellent and solution-oriented lawyer' recommended for dispute resolution practice by the renowned The Legal 500. In 2017, WTR1000 has recognised the firm as World's Leading Trademark Professionals.

Areas of practice: Litigation and ADR: this practice group assists clients with pragmatic and strategic decision-making in litigation and ADR matters. The practice group focuses on all types of litigation instituted and prosecuted within India and abroad, including commercial disputes, recovery proceedings, property disputes, infringement of intellectual property rights, constitutional matters, custody claims, service matters, banking claims, insolvency, criminal matters and other disputes. It also has expertise in handling matters involving white-collar crimes. The practice group has successfully undertaken and represented clients in international arbitrations including under the rules of the International Chamber of Commerce (ICC), the London Court of International Arbitration (LCIA), London Maritime Arbitration Association (LMAA) and the Singapore International Arbitration Center (SIAC).

Contracts and transactions: this practice group of dedicated and experienced lawyers excels in drafting, negotiating, structuring and closing all kinds of commercial transactions for both domestic and international clients including international joint ventures, private equity and venture transactions, takeover, partnership, franchisee and licence agreements and more. The group has extensive experience in commercial advisory services, including contract compliance and management, advising and assisting clients on regulatory issues for various sectors like real estate and infrastructure projects, waterways, energy, pharmaceuticals and healthcare, shipping and mining, education, food and beverages, manufacturing, employment and labour, banking and project finance, tender and bid documents.

Corporate and tax: the practice group renders services such as corporate advisory, company formations and tax structuring, mergers and acquisitions, management buyouts, project finance, venture capital, issues relating to banking, equity markets, foreign direct investment, exchange control, stock and asset purchases, restructuring and private equity and venture capital investments, foreign investments, regulatory approvals, investment structuring, import/export, securitisation, due diligence, feasibility studies, corporate legal audits, liability analysis, retail and direct marketing etc. The group also has experience in taxation laws and regularly advises and assists its domestic and international clients with respect to indirect taxation laws such as excise, VAT, service tax etc.

Intellectual property rights: the practice group comprises patent attorneys, patent agents, technology analysts, engineers, trade mark attorneys, trade mark agents, IPR trained paralegal and dedicated support staff committed to protecting and promoting intellectual property that facilitates businesses around the world. The group covers the complete spectrum of services in patents, trade marks, domain names, copyrights, geographical indications (appellations of origin), designs, and other related rights.

  • Number of lawyers: 72
  • Languages
  • English
  • Hindi
  • Member
  • International Bar Association
  • New York State Bar Association
  • International Trademark Association
  • Inter-Pacific Bar Association (IPBA)
  • Supreme Court Bar Association
  • Indo-German Chamber of Commerce
  • Delhi High Court Bar Association
  • Alliance of Business Lawyers
  • Indo-American Chamber of Commerce & Industry
  • Indo-China Chamber of Commerce
  • Indo-Italian Chamber of Commerce & Industry
  • Chartered Institute of Arbitrators (CIArb)
  • Confederation of Indian Industries
  • The Associated Chambers of Commerce & Industry of India

Above material supplied by Singh & Associates Founder – Manoj K Singh Advocates and Solicit.

Legal Developments by:
Singh & Associates Founder – Manoj K Singh Advocates and Solicit


    - Singh & Associates Founder – Manoj K Singh A

Legal Developments in India

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to

  • Post Marketing Surveillance of Drugs

    Post marketing surveillance is performed after market approval/clinical trials of drugs in India. The regulatory framework for conducting clinical trials of drugs is provided under the Drugs and Cosmetics Act, 1940 (“ Act ”) and the Drugs and Cosmetics Rules, 1945 (“ Rules ”). Further, Part X-A and Schedule Y of the Rules specifically deal with the statutory provisions applicable for clinical trial of drugs in India. Schedule Y divides Clinical trial of drugs into 4 Phases, namely, Human Pharmacology (Phase-I), Therapeutic exploratory trials (Phase-II), Therapeutic confirmatory trials (Phase III) and Post Marketing Trials (Phase-IV).
  • Protection of Biotechnology under Indian Laws

    According to the eighth annual survey conducted by the Association of Biotechnology-Led Enterprises (ABLE) and Bio Spectrum, the Indian biotech industry grew threefold in just five years to report revenues of US$ 3 billion in 2009-10, a rise of 17 per cent over the previous year. Maintaining the momentum of the previous years, the Indian biotech industry grew 16.28 per cent in FY2014; the total industry size was US$ 5 billion at the end of the financial year and it reached US$ 7 billion in FY2015. Fast-paced growth is likely to continue; the industry is expected to increase in size to USD11.6 billion by 2017, driven by a range   of factors such as growing demand, intensive R & D activities and strong government initiatives ( )
  • Cabinet Approves India’s IPR Policy - “Creative India; Innovative India: रचनात्म??

    The Union Cabinet on 13 May 2016 approved the National Intellectual Property Right (IPR) policy roadmap ( ) to foster creativity and innovation, promote entrepreneurship and enhance socio development, enhance access to healthcare, food security and environmental protection. The Policy recognizes the abundance of creative and innovative energies that flow in India, and the need to tap into and channelize these energies towards a better and brighter future for all.
  • Real Estate - India

    Real Estate - India
  • SEBI’s Jurisdiction | Analysis of the Supreme Court judgment in the Sahara case

    The Securities and Exchange Board of India (SEBI) is responsible for investor protection and development and regulation of the securities market in India. The scope of SEBI’s jurisdiction over the issue of securities by public companies is an important issue. This issue was recently considered by the Supreme Court in Sahara India Real Estate Corporation Ltd. and Ors. v. Securities and Exchange Board of India and Anr., MANU/SC/0702/2012; (2012) 8 SCALE 101. This article analyses this judgment and its implications.
  • Mainstreaming the Alternative: Issuance of NCDs

    Debt financing is a significant means for corporates to raise capital. Indian regulators have taken a number of steps to deepen the Indian debt market. Permission has been granted to foreign institutional investors (FIIs) and qualified foreign investors (QFIs) to invest in non-convertible debentures (NCDs) issued by Indian companies. This article summarises the legal and regulatory requirements for Indian companies to issue NCDs to FIIs and QFIs.
  • Options – Not a Part of History Yet

    At the time when India is completing two decades of the economic liberalization there are several laurels which the policymakers can boast of.   The path-breaking shift from the license-raj to a regime focusing on regulation introduced by the Government of India in the landmark year 1991 have been continued through further economic reforms and the same has also found support from the regulators and the market players.
  • Liberalization Back on Track with the Relaxation of Share Transfer Norms

    Soon after the rollback of the much criticized aspect of the Consolidated Foreign Direct Investment policy dated October 1, 2011 which treated foreign investments in Indian securities as external commercial borrowings in case such investments conferred options on the foreign investors, the policy makers have brought more good news for the investor community.
  • Franchising in India

    In the last two decades, India has witnessed a sea change in its foreign investment policy resulting in it being one of the most preferred investment destinations. With growing globalisation and liberalisation, brand awareness has been created in the Indian masses and today India is the one of the biggest and fastest emerging markets for various businesses across the world. Being geographically vast and culturally diverse, India offers the most favorable franchising environment with a huge consumer market. Franchising in this respect has managed to pick up as a successful business module for local companies in India.